WallStreetZenWallStreetZen

NASDAQ: BMRN
Biomarin Pharmaceutical Inc Earnings & Revenue

BMRN past earnings growth

How has BMRN's earnings growth performed historically?
Company
194.59%
Industry
23.97%
Market
129.89%
BMRN's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
BMRN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
BMRN's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

BMRN past revenue growth

How has BMRN's revenue growth performed historically?
Company
13.74%
Industry
89.08%
Market
19.74%
BMRN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BMRN's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BMRN's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BMRN earnings and revenue history

Current Revenue
$2.5B
Current Earnings
$205.5M
Current Profit Margin
8.3%

BMRN Return on Equity

Current Company
4.2%
Current Industry
16.8%
Current Market
28.2%
BMRN's Return on Equity (4.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BMRN announces earnings.

BMRN Return on Assets

Current Company
3%
Current Industry
3.2%
BMRN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BMRN Return on Capital Employed

Current Company
4.4%
Current Industry
-42.4%
BMRN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BMRN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BMRN$2.47B$359.85M$205.46M+10.23%+14.24%
RPRX$2.24B$983.33M$798.86M+4.46%+57.82%
BGNE$2.76B-$713.52M-$784.43M+62.54%N/A
GMAB$2.56BN/A$784.32M+42.16%+29.55%
SRPT$1.40B$91.13M$16.90M+34.11%N/A

BMRN earnings dates

Next earnings date
Jul 29, 2024

Biomarin Pharmaceutical Earnings & Revenue FAQ

What were BMRN's earnings last quarter?

On Invalid Date, Biomarin Pharmaceutical (NASDAQ: BMRN) reported Q1 2024 earnings per share (EPS) of $0.47, up 74.07% year over year. Total Biomarin Pharmaceutical earnings for the quarter were $88.66 million. In the same quarter last year, Biomarin Pharmaceutical's earnings per share (EPS) was $0.27.

If you're new to stock investing, here's how to buy Biomarin Pharmaceutical stock.

What was BMRN's earnings growth in the past year?

As of Q3 2024, Biomarin Pharmaceutical's earnings has grown 194.59% year over year. This is 170.63 percentage points higher than the US Biotechnology industry earnings growth rate of 23.97%. Biomarin Pharmaceutical's earnings in the past year totalled $205.46 million.

What is BMRN's earnings date?

Biomarin Pharmaceutical's earnings date is Invalid Date. Add BMRN to your watchlist to be reminded of BMRN's next earnings announcement.

What was BMRN's revenue last quarter?

On Invalid Date, Biomarin Pharmaceutical (NASDAQ: BMRN) reported Q1 2024 revenue of $648.83 million up 8.79% year over year. In the same quarter last year, Biomarin Pharmaceutical's revenue was $596.42 million.

What was BMRN's revenue growth in the past year?

As of Q3 2024, Biomarin Pharmaceutical's revenue has grown 13.74% year over year. This is 75.34 percentage points lower than the US Biotechnology industry revenue growth rate of 89.08%. Biomarin Pharmaceutical's revenue in the past year totalled $2.47 billion.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.